Wikipedia -WSS

Wikipedia

author：explore 2025-09-06 03:57:17 - browse：15

Christopher Boerner -- biotech JPM coverage from STAT — Bristol CEO Christopher Boerner Business Wire via AP

SAN FRANCISCO — Christopher Boerner has been the CEO of Bristol Myers Squibb for just two months. But in trying to sell the company to investors on Monday at the annual J.P. Morgan Healthcare Conference, he pointed to the company’s 150-year history.

He spoke of the “next chapter” for BMS, which saw its stock fall 27% last year, and said that the company would be going through a “period of renewal.” Basically, the tide comes in, but it also goes out. Patents on big-selling medicines expire, but new medicines will come to take their place.

Investors may not be able to view those changes with equanimity. Sales of Bristol’s top sellers will decline significantly or vanish as generic or biosimilar medicines emerge. That includes Eliquis, the blood thinner for stroke prevention that will be one of the first medications subject to price negotiation under the Inflation Reduction Act; Revlimid, the best-selling multiple myeloma medicine that Bristol acquired when it bought Celgene for $74 billion in 2019; and Opdivo, Bristol’s pioneering cancer immunotherapy, which is an $8 billion seller.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

Wikipedia

WSS

Nobel honors Karikó and Weissman's enduring partnership

With Roe v Wade overturned, abortion providers work to adapt

A preacher's new calling: Diversifying neuroscience research

Hospital chaplains balance Covid safety with patients’ spiritual needs

Allen Institute goes after foundational questions, CEO Costa says

Congress extends some pandemic preparedness programs

explore

Wikipedia

Wikipedia

New air purifier tech could be key to improving indoor air quality

Boston Scientific acquires urology company Axonics for $3.7 billion

United colonoscopy coverage change 'may cost lives,' doctors say

Ascension's ugly legal battle over care for poor patients in Texas

Sports medicine is finally prioritizing gender equality

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

Peter Hotez and the public health issue of online harassment

STAT Virtual Event: JPM Recap, Live!

After affirmative action ruling, medical educators look to 'holistic review'

6 solutions to address cancer drug shortages and others

hotspot

Flu, Covid vaccination rates decline, new survey data show

American taxpayers paid $1.8 trillion in health care costs in 2022

Nobel honors Karikó and Weissman's enduring partnership

European officials brace for rough respiratory virus season

Physician assistants need a new name. Here's what it should be

Setback for rare diseases as Taysha Gene Therapies pulls back

leisure time

explore

Wikipedia

leisure time